These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 16296749

  • 1. Pegylated IFNs for chronic hepatitis C: an update.
    Grace MJ, Cutler DL, Bordens RW.
    Expert Opin Drug Deliv; 2005 Mar; 2(2):219-26. PubMed ID: 16296749
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin.
    Asahina Y, Izumi N, Umeda N, Hosokawa T, Ueda K, Doi F, Tsuchiya K, Nakanishi H, Matsunaga K, Kitamura T, Kurosaki M, Uchihara M, Higaki M, Miyake S.
    J Viral Hepat; 2007 Jun; 14(6):396-403. PubMed ID: 17501760
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Review article: pegylated interferons: chemical and clinical differences.
    Foster GR.
    Aliment Pharmacol Ther; 2004 Oct 15; 20(8):825-30. PubMed ID: 15479353
    [Abstract] [Full Text] [Related]

  • 6. Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C.
    McHutchison J, Sulkowski M.
    J Viral Hepat; 2008 Jul 15; 15(7):475-81. PubMed ID: 18363672
    [Abstract] [Full Text] [Related]

  • 7. Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway.
    Grace MJ, Cutler D.
    Antivir Chem Chemother; 2004 Nov 15; 15(6):287-97. PubMed ID: 15646642
    [Abstract] [Full Text] [Related]

  • 8. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A, Tornai I, Szalay F.
    Orv Hetil; 2007 May 06; 148(18):819-26. PubMed ID: 17468063
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristics of hepatitis C treatment with pegylated interferons and ribavirin.
    Jiménez-Méndez R, Castañeda-Hernández G.
    Ann Hepatol; 2010 May 06; 9 Suppl():61-4. PubMed ID: 20713998
    [Abstract] [Full Text] [Related]

  • 12. Pegylated interferons.
    Karnam US, Reddy KR.
    Clin Liver Dis; 2003 Feb 06; 7(1):139-48. PubMed ID: 12691463
    [Abstract] [Full Text] [Related]

  • 13. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
    Napoli N, Giannelli G, Parisi CV, Antonaci A, Maddalena G, Antonaci S.
    New Microbiol; 2005 Jan 06; 28(1):13-21. PubMed ID: 15782622
    [Abstract] [Full Text] [Related]

  • 14. Pegylated interferons.
    Baker DE.
    Rev Gastroenterol Disord; 2001 Jan 06; 1(2):87-99. PubMed ID: 12120178
    [Abstract] [Full Text] [Related]

  • 15. Treatment of chronic hepatitis C infection with peginterferons plus ribavirin.
    Fried MW, Hadziyannis SJ.
    Semin Liver Dis; 2004 Jan 06; 24 Suppl 2():47-54. PubMed ID: 15346246
    [Abstract] [Full Text] [Related]

  • 16. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.
    Kamal SM, El Tawil AA, Nakano T, He Q, Rasenack J, Hakam SA, Saleh WA, Ismail A, Aziz AA, Madwar MA.
    Gut; 2005 Jun 06; 54(6):858-66. PubMed ID: 15888797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Peginterferon alpha-2b: a new approach to improving response in hepatitis C patients.
    Patel K, McHutchison J.
    Expert Opin Pharmacother; 2001 Aug 06; 2(8):1307-15. PubMed ID: 11584999
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.